Improve understanding of the biological pathology mechanism and secure your clinical trials.
Select your drug candidates at early stage based on their actions and properties.
Improve understanding of the biological pathology mechanism and secure your clinical trials.
Select your drug candidates at early stage based on their actions and properties.
No need to develop different antibodies to quantify your drug candidate. LC-MS multiplex capabilities allows quantification of your compounds in one analysis.
With our knowledge and expertise we can develop a method to quantify two proteins with only few amino acids differences
Specificity of methods we develop allows the quantification of several PTM on your drug target
Use an orthogonal approach to improve understanding of your assays
> Triage new compounds with high sequence homologies
> Avoid immunoassay development at early stages
> Specify impact of your drug on PTM of your drug target
> Identify and quantify PTM to understand biological pathology mechanism
> Understand action of your drug on your target
> Secure your clinical trials with selection of patient with good drug target expression